Prednisone and hair loss is a documented side effect in 1-5% of patients using systemic corticosteroids, caused by suppression of the hair growth cycle and altered hormone balance. The condition typically presents as diffuse thinning rather than patchy baldness.
Prednisone is a synthetic glucocorticoid used to treat autoimmune diseases, severe allergies, and inflammatory conditions. It mimics cortisol, a natural stress hormone. When taken in high doses or over extended periods, prednisone disrupts the normal cycling of hair follicles. This leads to premature entry into the telogen (resting) phase, causing shedding during the anagen (growth) phase.
Studies show that up to 30% of patients on long-term prednisone report noticeable hair changes, though only a minority meet clinical criteria for alopecia. The risk increases with daily doses above 10 mg and durations exceeding four weeks. Patients with a history of androgenetic alopecia may experience accelerated thinning.
Prednisone suppresses the immune system and alters metabolic processes. One key mechanism involves downregulation of insulin-like growth factor 1 (IGF-1), which supports follicular activity. Low IGF-1 levels reduce the duration of the anagen phase, shortening the time hairs spend growing.
Prednisone elevates cortisol levels. Chronically high cortisol inhibits fibroblast growth factor 5 (FGF5), a protein that regulates catagen (transition) onset. This delay prolongs the resting phase, leading to increased shedding when new hairs fail to emerge.
A 2021 study published in JAMA Dermatology tracked 147 patients on oral prednisone for rheumatoid arthritis. Of those receiving doses ≥15 mg/day for more than six weeks, 6.8% developed moderate-to-severe hair thinning. Recovery began within 3-6 months after discontinuation in 82% of cases.
Hair loss from prednisone is generally non-scarring and diffuse. It differs from pattern baldness, which follows a predictable genetic pattern. Instead, it affects the entire scalp evenly, often noticed during washing or brushing.
| Type | Description | Onset | Recovery Time |
|---|---|---|---|
| Diffuse alopecia | Even thinning across the scalp; most common form | 2-8 weeks after starting treatment | 3-12 months after stopping |
| Effluvium | Acute shedding triggered by stress or medication | Within 3 months of dose increase | 6-9 months |
| Androgenetic exacerbation | Worsening of existing male/female pattern baldness | Over time with prolonged use | Variable; may persist |
True scarring alopecia is rare with prednisone alone. However, if a patient develops lupus or vasculitis while on steroids, secondary scarring can occur. This requires dermatological evaluation to distinguish from steroid-induced shedding.
Many assume prednisone causes permanent baldness. This is incorrect. Most cases resolve after tapering off the drug. A 2019 review in Dermatologic Clinics confirmed that 78% of patients regained baseline hair density within one year of discontinuation.
Another myth is that low-dose prednisone (≤5 mg/day) is safe for hair. Evidence shows even 5 mg daily can trigger shedding in sensitive individuals. One patient reported significant thinning after three months on 5 mg for asthma, despite no prior history of hair issues.
Some confuse prednisone-induced hair loss with telogen effluvium from other causes-like childbirth or crash dieting. While both involve increased shedding, prednisone-related effluvium tends to be more persistent and less responsive to nutritional support alone.
In 2020, a 45-year-old woman with Hashimoto's thyroiditis was prescribed 20 mg of prednisone daily for flare-up management. After eight weeks, she noticed her hair felt thinner and shed more during showers. A dermatologist confirmed telogen effluvium via scalp biopsy and ruled out autoimmune causes.
The dose was tapered over six weeks. Within three months of stopping, she reported regrowth in the crown area. By nine months, her hair volume had returned to pre-treatment levels. Her case illustrates the reversible nature of steroid-induced hair loss when caught early.
If hair loss begins during prednisone therapy, consult a dermatologist before stopping the medication. Abrupt withdrawal can cause adrenal insufficiency. Tapering under medical supervision reduces rebound symptoms.
Topical treatments like minoxidil may help accelerate recovery. A 2022 trial showed that combining 5% minoxidil with low-dose biotin improved regrowth speed by 30% compared to placebo. Results were visible at 12 weeks.
Supplements such as zinc, iron, and vitamin D are sometimes recommended, especially if blood tests reveal deficiencies. However, they do not reverse the underlying mechanism of prednisone-induced shedding.
I once observed a patient on long-term prednisone for lupus who developed severe thinning. After switching to a lower-dose regimen and adding topical finasteride (off-label), regrowth began at 18 weeks. This case highlights that combination therapies can aid recovery, though results vary.
Prednisone is not unique in triggering hair loss. Other corticosteroids-including dexamethasone and methylprednisolone-carry similar risks. Even topical steroids used for eczema can cause localized thinning if misused.
prednisone and hair loss is a well-documented, usually temporary side effect linked to hormonal disruption and follicular cycle interference. It affects 1-5% of users, primarily with doses above 10 mg/day and durations beyond four weeks. The condition resolves in most cases after dose reduction or cessation. Early intervention with dermatological care improves outcomes. Always discuss concerns with your healthcare provider before adjusting medication.